Arthritis

CHICAGO — New techniques and implants to treat carpometacarpal arthritis may soon take the place of ligament reconstruction with tendon interposition for this indication, providing better pinch strength and other benefits, a speaker said.

The benefits of statins in reducing cardiovascular disease and mortality “outweigh” the associated increased risk for type 2 diabetes in patients with rheumatoid arthritis, according to data published in Arthritis Care & Research.

The burden of hip osteoarthritis has increased globally in the past 30 years, with incidence and disability-adjusted life years rising “in nearly all countries,” according to data published in Arthritis Research & Therapy.

Sinusitis, acute respiratory tract burden and even pharyngitis — also known as the common cold — are potential risk factors for rheumatoid arthritis, according to data published in The Journal of Rheumatology.

The FDA has approved the seventh biosimilar to adalimumab, adalimumab-aqvh, for all eligible indications of the biologic product, the latest in an increasingly crowded biosimilar logjam set to release in 2023.

Patients developing rheumatoid arthritis can experience a 30% loss in work productivity a full year before the disease clinically manifests, according to data published in Rheumatology.

Physical activity, defined as recreational whole-body physiological energy expenditure, and time spent in physical activity are not associated with knee osteoarthritis outcomes, according to data published in Arthritis & Rheumatology.

Recent data found that dermatomyositis was more prevalent than had been thought. The retrospective, population-based cohort study that led to this conclusion was the top story in rheumatology last week.

A median of just 16.2% of adults with arthritis attended a self-management class in 2019, while that same year 69.3% received counseling for physical activity from their provider, according to CDC researchers.

Secukinumab is efficacious in children and adolescents with psoriatic arthritis and enthesitis-related arthritis, resulting in a significantly longer time to flare versus placebo, according to data presented at ACR Convergence 2021.